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Summary 
A cDNA encoding an allergenic protein was isolated from an Aspergillusfumigatus  (/1. fumigatus) 
cDNA library displayed on the surface of filamentous phage. Serum immunoglobulin E  (IgE) 
from A. fumigatus--sensitized  individuals was  used to  enrich phage-expressing gene products 
binding to IgE. One of the cDNAs encoded a 26.7-kD protein that was identified as a manga- 
nese superoxide dismutase (MnSOD) sharing 51.5% identity and 67.2% homology to the cor- 
responding human enzyme. Both human and A. fumigatus MnSOD coding sequences were ex- 
pressed in Escherichia coli as [His]6-tagged fusion proteins and purified by Ni2+-chelate affinity 
chromatography. The two  recombinant MnSODs  were both recognized by IgE  antibodies 
from subjects allergic to the A. fumigatus MnSOD and elicited specific immediate type allergic 
skin reactions in these individuals. Moreover, both human and A. fumigatus MnSOD induced 
proliferation  in  peripheral  blood  monouuclear  cells  of A.  fumigatus-allergic  subjects  who 
showed specific IgE responses and reacted in skin tests to MnSOD. These observations provide 
evidence for autoreactivity to the human MnSOD in allergic persons sensitized to an environ- 
mental allergen from A.fumigatus who share a high degree of  sequence homology to the corre- 
sponding human enzyme. 
M 
embers of the genus Aspergillus  are ubiquitously dis- 
tributed fungi that are considered opportunistic patho- 
gens.  They are associated with a wide spectrum of diseases 
in humans and animals,  ranging from benign colonization 
of the lung and allergy to life-threatening diseases such as 
invasive aspergillosis  or allergic broncho-pulmonary asper- 
gillosis (1). Aspergillusfumigatus  is the etiologic agent identi- 
fied in  80% of Aspergillus-related human diseases  and is of 
particular clinical relevance. A variety of underlying condi- 
tions, including impaired immune status,  contribute to de- 
velopment of aspergillosis  (2). However, the pathophysio- 
logic mechanisms leading to Aspergillus-related pulmonary 
complications are largely unknown. A better understanding 
of the mechanisms leading to fungal allergy requires more 
information about structure and function of the antigens/ 
allergens  involved.  Cloning  and  sequencing  of allergen- 
encoding cDNAs have permitted the functional character- 
ization of  some allergens by sequence comparison with those 
of known  proteins.  The  spectrum  ranges  from  enzymes 
such as proteases (3) or phospholipases (4) to pathogenesis- 
related or structural plant proteins (5).  From A. fumigatus, 
the 18-kD protein Asp fl, a member of the ribotoxins (6), 
has been cloned (7), produced, and shown to be a major al- 
lergen suitable for in vivo and in vitro diagnosis of sensiti- 
zation to A. fumigatus (8, 9). 
We cloned cDNAs encoding allergenic A. fumigatus pro- 
teins distinct from Asp fl using a new technology based on 
display ofcDNA libraries on the surface of filamentous phage 
(10,  11). Here, we describe the sequence and properties of 
one of these allergens, identified as an A.fumigatus superox- 
ide dismutase  (SOD; E.C.  1.15.1.1.), by sequence homol- 
ogy and enzymatic activity (12). The protein is recognized 
by  IgE  antibodies  of individuals  allergic  to A. fumigatus, 
shows strong humoral cross-reactivity to human manganese 
superoxide dismutase (MnSOD), and both human and fun- 
gal MnSODs induce strong responses in PBMC. 
Materials and Methods 
Construction of a eDNA Library Displayed on Phage Surface and 
Biopanning.  An A. fumigatus cDNA library was constructed  in 
phagemide pJuFo (10) and displayed on the surface of  filamentous 
phage M13 as described (11). The library was selectively enriched 
for phage displaying IgE-binding proteins by biopanning  in mi- 
crotiter plates coated with serum IgE from individuals allergic to 
A. fumigatus. Serum donors were selected according to case his- 
tory, specific IgE to A. fumigatus determined by radioaUergosor- 
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Figure 1.  Amino acid sequences of human (21) and yeast (25) MnSOD aligned with the A.fumigatus MnSOD sequence. Identical amino acid residues 
are marked by vertical lines. Gaps are indicated by dots. Sequence identity between A. fumigatus and human MnSOD is 51.5% and between A. fumigatus 
and yeast MnSOD 50.75%, whereas sequence identity with the MnSOD from other species varied between 30 and 49%. Numbers above the sequence 
indicate the residue number, including  gaps, starting at the NH2-temfinal lysine of the mature human enzyme. 
bent test (R_AST), and skin reactivity to commercial A. fumigatus 
extracts  (8). A  wide variety of phage binding to human IgE was 
isolated (11). 
Identification of a Clone Encoding A. fumigatus MnSOD.  Selected 
clones differing in the length of the inserts were sequenced using 
the dideoxynucleotide chain termination method (13). Both DNA 
strands were sequenced using vector-derived primers. Homology 
searches  were  performed with BLAST and the  Genetics Com- 
puter Group program FASTA (14, 15). Clone 19 revealed strong 
homology with  nucleotide sequences encoding superoxide  dis- 
mutases (Fig. 1). 
Cloning of the Human MnSOD,  Production, and Characterization 
of Recombinant Proteins.  The  cDNA  encoding human MnSOD 
was amplified by standard PCI< (16)  from a  commercial human 
lymphoma U937  lung cDNA library (Stratagene,  La JoUa,  CA) 
using the following primers: 5'-primer 5'-GGAAGATCTAAG- 
CACAGCCTCCCCGACCTGCCC-Y; 3'-primer 5'  -CCCAAG- 
CTTTTACTTTTTGCAAGCCATGTATCTTTC-3'.  The com- 
plete  cDNA  encoding the  putative A. fumigatus  MnSOD  was 
amplified from the  original clone by PCP- using the  following 
primers: 5'-primer 5'-GGAAGATCTCAATACACGCTCCCA- 
CCCCTCC-Y,  Y-primer  5'-CCCAAGCTTTCACAGCTT- 
CATGAATGGG-Y. PCtk cycling conditions were 94~  for 60 s, 
53~  for 60 s, and 72~  for 60 s for 30 cycles, foUowed by a ter- 
minal extension  cycle  at  72~  for  10  rain.  The  amplification 
products  were  purified over  QIAquick spin columns (Quiagen 
Inc., Chatsworth,  CA), digested with BgllI and HindlII, ligated 
to BamHl/HindlII-restricted  p(His)6-DHFR vector (17) and trans- 
formed into E. coli strain M15 (7) by etectroporation (18). Trans- 
formants were  grown in liquid culture to  verify the  nucleotide 
sequence (13)  and used to produce hexahistidine-tagged recom- 
binant proteins as described (7,  17). The fusion proteins were pu- 
rified in  a  single step  by  Ni2+-chelate  affinity chromatography 
(17)  to  obtain recombinant proteins of high purity.  Purity and 
molecular size  of the proteins were  analyzed by polyacrylamide 
gradient  gels  (12.5-20%)  using  standard  procedures  (19),  and 
were shown to be biologically active by determination of the en- 
zymatic activity of the preparations (12). 
ELISA and IgE Immunoblots.  The specific binding of human 
serum IgE from individuals sensitized to A. fumigatus to recombi- 
nant human and A. fumigatus MnSOD was analyzed by an anti- 
gen-specific ELISA as described previously (8). Inhibition ELISAs 
were performed to demonstrate that the enzymes share common 
epitopes.  For IgE  immunoblot analysis, proteins were  separated 
on an SDS-polyacrylamide gradient gel  (12.5-20%),  transferred 
to  Hybond-ELC  nitrocellulose (Amersham, Arlington Heights, 
IL), incubated with patient sera diluted 1:I0 as "first antibody," 
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followed by incubation with mouse anti-human IgE mAb TN- 
142  (8)  as second antibody. Western blots were  developed with 
the ECL system (Amersham) using horseradish peroxidase-conju- 
gated goat anti-mouse Ig (Tago, Inc., Burlingame, CA) as a de- 
tection system. 
Proliferative Responses of PBMC from Individuals Sensitized to A. 
fumigatus MnSOD.  PBMC aliquots (106 cells/ml) isolated.from 
heparinized blood samples from individuals sensitized to A. fumi- 
gatus MnSOD  were  stimulated with different concentrations of 
A. fumigatus extract, recombinant human, or A. fumigatus MnSOD 
for 7  d.  Proliferation was measured as incorporation of tritiated 
thymidine during the final 16 h  of culture. A  stimulation index 
>3 was considered as positive. 
Skin Tests with Recombinant MnSOD.  Lyophilized  recombi- 
nant protein (1 mg) was dissolved in 1 ml 0.9% saline and diluted 
at serial 10-fold dilutions. For intradermal skin tests,  100 Ixl of the 
solutions were injected with a syringe starting from a concentra- 
tion of 10  -5 to  1  Ixg m1-1. 0.01% histamine dihydrochloride and 
0.9% saline were used as positive and negative controls, respec- 
tively.  The  skin reactions were  recorded  after  15  min and  re- 
Figure 2.  Autoradiography of IgE immunoblots: molecular mass stan- 
dards (in kilodahons) are indicated at the left side. Each recombinant  pro- 
tein (1 t~g) was separated on an SDS-polyacrylamide gradient gel (12.5- 
20%) and blotted  onto a nitrocellulose membrane.  The membrane was 
incubated with serum from A. fumigatus-allerfflc patients diluted  1:10 in 
50 mM sodium phosphate, pH 7.4, 5% Tween 20, 2% BSA. Bound IgE 
was identified  by enhanced chemiluminescence  detection  (8). Lane  1, 
marker  proteins  as negative  control;  lane  2,  recombinant A. fumigatus 
MnSOD; lane 3, recombinant  human MnSOD. garded positive if the wheal was at least half the size of the skin 
reaction induced by the positive histamine control (8). An ethical 
approval for skin testing human subjects with recombinant pro- 
teins was provided via the local ethics committee. A full explana- 
tion of the procedure was given to all participants, and their writ- 
ten consent was obtained before testing. 
Results  and  Discussion 
Isolation of eDNA  Clones and Sequence of the A. fumigatus 
MnSOD.  Cloning of cDNA libraries on phagemid pJuFo 
(10) and display of the expression products on the surface 
of filamentous phage  (11,  20)  allow efficient isolation of 
cDNAs that encode proteins for which a ligand is available. 
The procedure circumvents immobilization of the libraries 
on solid-phase supports that hamper selective enrichment 
of clones expressing the desired protein. We have gener- 
ated a cDNA library from A. fumigatus displayed on the sur- 
face of the filamentous phage M13, which was screened for 
displayed gene products binding to human serum IgE from 
patients allergic to the fungus (11). The large phage popu- 
lation obtained after selective enrichment by ligand-prod- 
uct interaction contained phage  encoding different aller- 
genic proteins as demonstrated by sequence determinations 
4 
3 
o  2 
,q- 
I 
!  I  I  T  1 
0.001  0.01  0.1  1  10  100 
Inhibitor  concentration 
[pg/ml] 
Figure 3.  Competitive inhibition of IgE binding to solid-phase-coated 
A. fumigatus recombinant MnSOD.  Serum from A. fumigatus-sensitized 
patients was preincubated with different amounts of recombinant A. fumi- 
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Figure  4.  Proliferative  responses  of PBMC 
from patients sensitized  to A. fumigatus to re- 
combinant A. fumigatus MnSOD  (O), recom- 
binant human MnSOD  (A), and A. fumigatus 
extract  (11). Representative dose  responses  to 
each of the  antigens in PBMC  from patients 
sensitized  to the fungal MnSOD are shown in 
A-C. Stimulation indices to optimal concentra- 
tion of the antigens for seven patients respond- 
ing to both recombinant A. fumigatus and hu- 
man MnSOD (~ ￿9  [] ￿9  A  +  X), one patient 
without  detectable  IgE  against  A. fumigatus 
MnSOD responding to the A. fumigatus extract 
alone (O), and three control subjects  (0 ￿9  +) 
are given in D. (our unpublished results).  Clone  19 containing an insert of 
751  bp consists of a coding region of 630 bp (bases 34-633) 
and  revealed strong homology with  nucleotide  sequences 
encoding superoxide dismutases. The 3'-noncoding region 
has a polyadenylated tail of 24 bp. The cDNA and deduced 
amino  acids  sequence  (210  residues)  were  submitted  to 
GeneBank/EMBL/DDBJ  (accession  number  U53561). 
The  deduced  amino  acid  sequence  of this  cDNA  clone 
(Fig.  1) was homologous to MnSOD,  showing the highest 
sequence  identity  of 48-52%  to  the  human  (21),  bovine 
(22)  fruit fly (23),  gum tree (24),  yeast (Saccharomyces cerevi- 
sae; 25), and Escherichia coli (26) enzyme. Apparently, the A. 
fumigatus  MnSOD  displays  a  similar  degree  of sequence 
identity  to  MnSOD  from a  wide  variety of phylogeneti- 
cally distant organisms. 
Manganese SOD is one of three enzyme forms that cata- 
lyze the dismutation of superoxide radicals.  The SODs are 
considered as the first line of defence against the toxicity of 
oxygen-related radicals and are widespread in all organisms 
that depend on oxygen (12).  Reactive oxygen species have 
been postulated to underlie the pathogenesis of various in- 
flammatory diseases  and to play important roles in  cellular 
defence including bactericidal action of  phagocytes (27, 28). 
Production and Characterization of Recombinant A. fumigatus 
and Human MnSOD.  The complete cDNA encoding the 
putative A. fumigatus  MnSOD was expressed in E. coli as a 
hexahistidine-tagged  fusion  protein  using  the  p(His)6- 
DHFR vector and purified by nickel-chelate affinity chro- 
matography  (17).  The  cDNA  encoding  human  MnSOD 
was isolated by PCR,  subcloned into  p(His)6-DHFR, ex- 
pressed,  and affinity purified.  Both recombinant MnSODs 
were  virtually  pure  when  analyzed  by  SDS-PAGE  and 
Coomassie blue staining and the estimated molecular mass 
was in agreement with the calculated values of 26.713  and 
25.725  kD  for the A. fumigatus  and  human MnSOD,  re- 
spectively  (data  not  shown).  The  recombinant  proteins 
were demonstrated to be enzymatically active and reached 
a  specific  activity varying from 2.32  to  2.61  U/rag,  de- 
pending  on  the  batch,  which  is  comparable to  the  enzy- 
matic activity of human  erythrocyte SOD  used  as a  stan- 
dard (2.45  ￿  103 U/mg; reference 29). 
Allergenic Properties of the MnSODs.  The  A. fumigatus 
MnSOD  was isolated as an  IgE binding protein displayed 
on phage surface and thus expected to be an allergen. How- 
ever, both A. fumigatus  and human recombinant MnSODs 
were  identified  as  relevant allergens  by IgE-immunoblots 
(Fig.  2)  and by ELISA assays with sera from 60 individuals 
suffering from A. fumigatus-related  complications (data not 
shown). The binding of serum IgE from patients allergic to 
A. fumigatus  to  solid-phase--bound  A. fumigatus  MnSOD 
was inhibited  by increasing  amounts  of recombinant  hu- 
man  MnSOD  added  to  the  fluid  phase  (Fig.  3),  demon- 
strafing  that  the  proteins  share  common  IgE-binding 
epitopes.  Although  both  proteins  are  able  to  fully inhibit 
the  binding  of IgE  to  A. fumigatus  MnSOD,  ~10  times 
more of human MnSOD was required to achieve the same 
inhibitory effect, indicating that serum IgE antibodies bind 
to human MnSOD with lower affinity. 
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Primary Proliferative Responses of PBMC from A. fumigatus 
Sensitized Individuals.  As allergen-specific IgE production 
is dependent on T  cell help, we measured the proliferative 
responses of mononuclear cells  from individuals  sensitized 
to A. fumigatus  to fungal extract, recombinant A. fumigatus 
MnSOD,  and  recombinant  human  MnSOD.  Individuals 
sensitized to the fungal MnSOD  had positive responses to 
both recombinant enzymes, whereas an A. fumigatus-sen- 
sitized  person  lacking  IgE  antibodies  against  the  fungal 
MnSOD responded to the fungal extract only. This also in- 
dicates that the recombinant antigens did not induce non- 
specific  effects.  Three  individuals  with  high  level  back- 
ground proliferation did not respond to any of the antigen 
preparations  (Fig.  4).  In additional  experiments, the  mean 
proliferative responses of six control individuals to A. fumi- 
gatus  extract,  fungal MnSOD,  and  human  MnSOD  were 
968,  1,388,  and  1,336 cpm, respectively. The mean prolif- 
erative responses of six individuals sensitized to  the fungal 
MnSOD to the same antigens were 6,981, 7,282, and 12,300 
Figure 5.  Skin  test reactivity  to human recombinant MnSOD. For in- 
tradermal skin tests, 100 Ixl of the solutions were injected with a syringe 
starting from a concentration of 10  ~4 p~g rnl-k 0.01% histamine dihydro- 
chloride and 0.9% saline were used as positive  and negative controls, re- 
spectively. The reactions show that 0.01 Ixg human MnSOD are able to 
elicit a wheal that is comparable  with the size of  the skin reaction induced 
by the positive  histamine control. cpm,  respectively.  Comparison  of the  values  by the  rank 
sum test indicates  highly significant differences  (P <0.01). 
These responses to a self antigen in individuals sensitized to 
the A. fumigatus MnSOD indicate an autoantigenic T  cell- 
mediated pathogenesis.  In many infectious diseases,  domi- 
nant antibody responses are directed towards microbial an- 
tigens with a high degree of homology to self proteins (30). 
Molecular mimicry at the T  cell level to homologous pep- 
tide sequences from human and microbial antigens has been 
demonstrated in several autoimmune diseases  (30, 31). 
In Vivo Relevance of the Recombinant MnSODs.  The final 
demonstration that a protein acts as an allergen is its ability 
to elicit type I skin reactions in allergic individuals.  There- 
fore,  we  investigated  whether  the  cross-reactivity  of the 
anti-MnSOD  IgE antibodies  is sufficient to provoke aller- 
gic reactions in vivo by skin tests (8).  Four individuals aUer- 
gic to A. fumigatus MnSOD,  two individuals  allergic to A. 
fumigatus proteins other than MnSOD, and two nonallergic 
control persons were tested for their ability to respond to 
intradermal  challenge  with  recombinant  A. fumigatus  and 
human MnSOD.  A  positive  skin  reaction  to A. fumigatus 
MnSOD was observed only in individuals who had detect- 
able IgE antibodies to A. fumigatus MnSOD.  These individ- 
uals  also  showed strong skin  reaction  to  human MnSOD 
challenge (Fig. 5). The immediate skin reaction depends on 
mast cells  that are rapidly degranulated  and release  media- 
tors, particularly histamine,  which is triggered through an- 
tigen-dependent  IgE cross-linking to specific receptors  on 
the mast cell membrane  (32).  These results  show that hu- 
man  MnSOD  is  able  to  elicit  IgE  cross-linking  on  mast 
cells in vivo, and they suggest a humoral autoimmune re- 
sponse in some of the patients  suffering from A. fumigatus 
allergy. 
In summary,  these  data  provide  strong  evidence  for in 
vitro and in vivo humoral and cell-mediated  autoimmune 
reactivity to human MnSOD in patients allergic to A. fumi- 
gatus. Whether the cause of these autoimmune reactions is 
caused by molecular mimicry between conserved T  and B 
cell epitopes present on the fungal and on the structurally re- 
lated human enzyme or by sensitization to human MnSOD 
due to an inflammatory process remains to be elucidated. 
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